Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06685783 · ClinicalTrials.gov registry record

Vis-Rx Prime Micro-Imaging Catheter Study

A clinical trial of Coronary Artery Disease, sponsored by Gentuity.

Active
Registry status
70
Enrollment target
3
Study locations

NCT06685783 is a study of Coronary Artery Disease that is active but no longer recruiting, run by Gentuity. The registered enrollment target is 70 participants, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06685783, a study of Coronary Artery Disease, is active but no longer recruiting, sponsored by Gentuity.

ACTIVE NOT RECRUITING
Registry status
70 participants
Enrollment target
3
Study locations

Study Summary

To study the performance of the Gentuity® HF-OCT Imaging System and Vis-Rx Prime® Micro-Imaging Catheter when used to obtain images of coronary arteries in patients who are undergoing cardiac catheterization and are candidates for interventional procedures. The study will evaluate ease of catheter use by physicians using the catheters, image quality and overall performance. The patient's involvement in the study ends when the cardiac catheterization/interventional procedure is completed.

Conditions Studied

Study Locations (3)

Illinois

  • Advocate Lutheran General Hospital - Park Ridge

New York

  • St. Francis Hospital and Heart Center - Roslyn

Ohio

  • Lindner Research Center at The Christ Hospital - Cincinnati

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2024-12-11
Est. Completion 2026-07

Sponsor

Gentuity

3 total trials

What the Registry Record Tells You About NCT06685783

The ClinicalTrials.gov registry entry for NCT06685783 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,287-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (95% lower). The listed sponsor is Gentuity, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.

NCT06685783 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Illinois, New York, Ohio.

Frequently Asked Questions

What is clinical trial NCT06685783 about?

NCT06685783 is a clinical study titled "Vis-Rx Prime Micro-Imaging Catheter Study". To study the performance of the Gentuity® HF-OCT Imaging System and Vis-Rx Prime® Micro-Imaging Catheter when used to obtain images of coronary arteries in patients who are undergoing cardiac catheterization and are candidates for interventional procedures. The study will evaluate ease of catheter u...

What is the current status of trial NCT06685783?

This trial is currently active not recruiting. The enrollment target is 70 participants. The study started on 2024-12-11. Estimated completion is 2026-07.

What conditions does trial NCT06685783 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

Who is sponsoring clinical trial NCT06685783?

This trial is sponsored by Gentuity, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06685783 being conducted?

This trial has 3 study locations across Illinois, New York, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.